Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, during which she focused her research on molecular biology, epigenetics and infectious diseases.
Orilissa (elagolix), an FDA-approved medication for managing endometriosis pain, lowers ovulation rates in a dose-dependent manner but does not seem to affect the amount of developing eggs in the ... Read more
Ovarian cysts negatively affect the quantity and quality of eggs produced by women with endometriosis-associated infertility, which may affect the outcomes of assisted reproduction, a study reports. The quality ... Read more
Results of small clinical study support the potential of oral nolasiban to improve pregnancy and live-birth rates among women undergoing embryo transfer following in vitro fertilization (IVF), ObsEva announced. These findings can ... Read more
SPIRIT 2, one of two pivotal Phase 3 clinical trials evaluating once daily relugolix pills combined with estradiol and progestin in treating pain in women with endometriosis, is now fully enrolled, its developer ... Read more
ObsEva announced the initiation of two key Phase 3 trials to confirm the safety and efficacy of its therapy linzagolix for endometriosis-associated pelvic pain and to support the therapy’s ... Read more
Diaphragmatic endometriosis is rare but may lead to a rupture of the diaphragm, the muscle essential for breathing, without any or very subtle symptoms, a case report and literature review details. The ... Read more
Despite being rare, endometriosis can appear or come back after menopause. Doctors should be aware of this, particularly if there are complaints of pelvic pain or heavy bleeding, and they ... Read more